Disclosure Panels Details Page
Genetic/Familial High-Risk Assessment: Colorectal Panel - Disclosures as of 07/02/2022
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Date Completed |
|---|---|---|---|---|---|
| Lisen Axell MS | None | None | None | None | 04/13/2022 |
| Marian Birkeland PhD | None | None | None | None | 03/08/2022 |
| Carol Burke MD | Emtora biosciences Freenome inc Janssen Pharmaceutica Products, LP |
freenome inc SLA pharma |
None | None | 12/24/2021 |
| Lee-May Chen MD | AstraZeneca Pharmaceuticals LP Genentech, Inc. GlaxoSmithKline |
None | None | None | 03/20/2022 |
| Daniel Chung MD | Immunovia Iterative Scopes Janssen Pharmaceutica Products, LP |
Guardant | None | None | 03/10/2022 |
| Katherine Clayback MS,CGC | None | None | None | None | 04/22/2022 |
| Eileen Cucinotta | None | None | None | None | 06/13/2022 |
| Susan Dallas | None | None | None | None | 01/03/2022 |
| Susan Darlow PhD | None | None | None | None | 03/11/2022 |
| Mary Dwyer MS | None | None | None | None | 06/20/2022 |
| Seth Felder MD | None | None | None | None | 05/13/2022 |
| Francis Giardiello MBA,MD | None | None | Steinberg Gastroenterology Board Review Course | None | 11/23/2021 |
| William Grady MD | Diacarta Janssen Pharmaceutica Products, LP Lucid Technologies Nephron Tempus |
Freenome Guardant Health SEngine |
WebMD | None | 05/31/2022 |
| Kristina Gregory OCN,MSN,RN | None | None | None | None | 03/27/2022 |
| Samir Gupta MD | Epigenomics Freenome |
Cellmax Guardant |
None | None | 02/06/2022 |
| Michael Hall MS,MD | Caris Life Sciences Invitae Myriad Genetic Laboratories, Inc. |
GRAIL | None | None | 12/13/2021 |
| Heather Hampel LGC,MS | National Cancer Institute | Genome Medical GI OnDemand Invitae Genetics Promega |
None | None | 10/05/2021 |
| Rachel Hodan MS,CGC | None | None | None | None | 06/06/2022 |
| Gregory Idos MS,MD | None | None | None | None | 11/19/2021 |
| Bryson Katona MD,PhD | Ambry Freenome GeneDx Guardant Immunovia Invitae Janssen Pharmaceutica Products, LP Universal Diagnostics |
None | None | None | 06/13/2022 |
| Moh'D Khushman MD | AstraZeneca Pharmaceuticals LP Bristol-Myers Squibb Company Ipsen |
Bayer HealthCare Taiho Parmaceuticals Co., Ltd. |
Pfizer Inc. | None | 02/25/2022 |
| Laura Lamps MD | None | Ibex Medical Analytics Scientific Symposiums International |
None | United States and Canadian Academy of Pathology | 05/19/2022 |
| Xavier Llor PhD,MD | None | None | None | None | 03/25/2022 |
| Patrick Lynch MD,JD | SLA Pharma | SLA Pharma | None | None | 11/26/2021 |
| Arnold Markowitz MD | None | None | None | None | 05/11/2022 |
| Mariana Niell-Swiller MS | None | None | None | None | 07/01/2022 |
| Sara Pirzadeh-Miller MS | None | None | None | None | 04/18/2022 |
| Donna Powell CMD,DHSc,RT(T) | None | None | None | None | 06/21/2022 |
| Jewel Samadder MD | Cancer Prevention Pharmaceuticals Janssen Pharmaceutica Products, LP |
Cancer Prevention Pharmaceuticals Janssen Pharmaceutica Products, LP Recursion Pharmaceuticals |
None | None | 12/05/2021 |
| David Shibata MD,FACS,FASCRS | None | None | None | None | 02/09/2022 |
| Peter Stanich MD | Emtora Biosciences Freenome Gaurdant Invitae Corp. Janssen Pharmaceutica Products, LP Pfizer Inc. PTEN Research foundation |
None | UpToDate, Inc. | Collaborative Group of the Americas on Inherited Gastrointestinal Cancers | 06/26/2022 |
| Benjamin Swanson PhD,MD | None | Cogen Bioscience | None | Cogen Bioscience | 03/29/2022 |
| Brittany Szymaniak PhD,CGC | None | "Technology-enhanced AcceleRation of Germline Evaluation for Therapy - The TARGET study" which has been funded by the Prostate Cancer Foundation. | UroGPO | None | 03/31/2022 |
| Jennifer Weiss MD,MS | Exact Sciences | None | American College of Physicians Medscape |
None | 02/09/2022 |
| Jeanna Welborn MD | None | None | None | None | 04/29/2022 |
| Georgia Wiesner MD | None | None | None | None | 06/14/2022 |
| Andrew Wolf MD | None | None | None | None | 06/09/2022 |
| Matthew Yurgelun MD | Janssen Pharmaceutica Products, LP | UpToDate | None | Facing Our Risk of Cancer Empowered (FORCE) advocacy group | 04/29/2022 |